Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluation. Dinardo G, Cafarotti A, Galletta F, Fiocchi A, et al. Pediatr Allergy Immunol 2023;34:e14057.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dinardo G, Cafarotti A, Galletta F, Fiocchi A, et al. Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two-year evaluation. Pediatr Allergy Immunol 2023;34:e14057.
PMID: 38146110